Published in Eur J Cancer on April 01, 2001
Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol (2002) 1.30
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. Neuro Oncol (2010) 1.22
Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Pediatr (2006) 0.83
Leukemia cancer mortality trend in iran, from 1995 to 2004. Iran J Cancer Prev (2013) 0.81
What can we learn from geographical comparisons of childhood cancer survival? Br J Cancer (2007) 0.78
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Successful small-bowel/liver transplantation. Lancet (1990) 4.85
Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
Results from a historical survey of the survival of cancer patients given Di Bella multitherapy. Cancer (1999) 2.68
[Passive smoking: an environmental health risk]. Ned Tijdschr Geneeskd (2004) 2.04
[The relationship between health gain and effort in mass screening for breast cancer]. Ned Tijdschr Geneeskd (1997) 1.95
An estimate of the heritable fraction of childhood cancer. Br J Cancer (1991) 1.89
Validation of cancer prevalence data from a postal survey by comparison with cancer registry records. Am J Epidemiol (1994) 1.86
Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med (1999) 1.82
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Improved techniques for kidney transplantation in mice. Microsurgery (1995) 1.63
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer (1998) 1.58
Childhood cancer survival in Europe. Ann Oncol (2003) 1.57
Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer (1998) 1.56
Gender differences in stage-adjusted bladder cancer survival. Urology (2000) 1.55
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) Eur J Cancer (1999) 1.55
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53
Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer (2000) 1.52
Guided tissue regeneration versus mucogingival surgery in the treatment of human buccal gingival recession. J Periodontol (1992) 1.51
Mesothelioma and non-occupational environmental exposure to asbestos. Lancet (1991) 1.50
Introduction: the EUROCARE II Study. Eur J Cancer (1998) 1.50
Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer (1996) 1.50
The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer (1998) 1.45
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer (2001) 1.43
Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer (1995) 1.42
Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer (1998) 1.41
[Disappointing effectiveness of population screening for cervical cancer]. Ned Tijdschr Geneeskd (1997) 1.39
Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer (1997) 1.38
[The drawbacks of diagnostic diligence]. Ned Tijdschr Geneeskd (1998) 1.38
[Prevention of cutaneous melanoma]. Ned Tijdschr Geneeskd (1999) 1.38
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation (1988) 1.36
A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol (1988) 1.35
Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet (2009) 1.35
The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer (1999) 1.34
Occupation and bladder cancer in males: a case-control study. Int J Cancer (1985) 1.33
Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer (2012) 1.32
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31
The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer (2008) 1.28
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol (2011) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol (2003) 1.27
Changes in long term prognosis for breast cancer in a Dutch cancer registry. BMJ (1994) 1.27
Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study. Cancer (1992) 1.26
Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.26
Gastrointestinal perforation: ultrasonographic diagnosis. Crit Ultrasound J (2013) 1.25
Population mixing and excess of childhood leukemia. BMJ (1993) 1.24
The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses. Eur J Cancer (2001) 1.24
Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer (2003) 1.22
Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. IARC Sci Publ (1986) 1.21
Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer (2001) 1.19
Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect (1999) 1.19
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study. BJU Int (2001) 1.18
Ultrasound examinations in pregnancy and childhood cancer. Lancet (1984) 1.17
Cancer survival in European adolescents and young adults. Eur J Cancer (2003) 1.17
Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol (2010) 1.17
MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed (1994) 1.13
Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer (1991) 1.13
Cancer in the very elderly Dutch population. Cancer (2000) 1.12
Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer (1995) 1.12
Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. Eur J Cancer (1998) 1.12
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health (1992) 1.12
Sensation and Distress of Pain Scales: reliability, validity, and sensitivity. J Nurs Meas (2001) 1.11
Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int J Cancer (1995) 1.10
Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome. Br J Cancer (2009) 1.10
Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer (1993) 1.09
Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med (2000) 1.09
Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. Clin Genet (2014) 1.08
Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-Up of 136 nonpreselected patients. Pediatr Cardiol (1999) 1.07
Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol (1999) 1.05
Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiat Environ Biophys (2003) 1.05
Excess of mesotheliomas after exposure to chrysotile in Balangero, Italy. Occup Environ Med (2008) 1.05
Population density and childhood leukaemia: results of the EUROCLUS Study. Eur J Cancer (1999) 1.04
[Mortality from tumors and other diseases of the respiratory system in cement-asbestos workers in Casale Monferrato. A historical cohort study]. Med Lav (1988) 1.04
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer (1996) 1.04
Risk factors for childhood acute non-lymphocytic leukemia: an association with maternal alcohol consumption during pregnancy? Cancer Epidemiol Biomarkers Prev (1994) 1.04
Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996. Ann Hematol (1999) 1.04
Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol (1992) 1.03
Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation (1996) 1.03